Wacker Biotech News Today

Go to selection page WACKER Expands Production Capacity for Biopharmaceuticals in San Diego Munich/San...

(Page 1) Wacker Chemie AG (Munich, Germany)announced that its mRNA competence center in Halle is to produce an active ingredient based on mRNA and lipid

Go to selection page Pantherna and WACKER Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals ...

US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028 Report Highlights: US Orphan Drugs Market Opportunity: > USD 150

Exyte named as general contractor (EPCQ contract partner) Project is part of the German government's program to prepare for future pandemics Implementation in less than 24 months thanks to ExyCell modular system Lighthouse project for the strategic growth segment of Biopharma and Life Sciences at Exyte Biotechnology and personalized medicine drive growth Exyte CEO Bchele: "Better medical care, faster healing processes, a higher life expectancy - all this facilitated with the support of ...

A messenger ribonucleic acid (mRNA) competence center is being built at the Halle Biotech site of German company Wacker Chemie AG (WACKER).

The excavators are set to roll onto the WACKER site in Halle. As announced by the company today, the development of the Biotech site into an mRNA...

/PRNewswire/ -- Exyte GmbH (Exyte), a global leader in the design, engineering and delivery of facilities for high-tech industries, is building a mRNA...

Wacker Biotech will begin GMP production of Phase I clinical material of Actym’s therapeutic candidate at its site in Amsterdam using its LIBATEC® technology. Both companies have already been working on technology transfer and initiation of scale-up production of ACTM-838, which is Actym’s lead clinical development candidate for solid tumor therapy and is on the company's immunotherapy platform called STACT.

BERKELEY, Calif. and AMSTERDAM, Feb. 28, 2022 /PRNewswire/ -- Actym Therapeutics, a biotechnology company focused on the discovery and development...